![]() |
市場調查報告書
商品編碼
1308675
2030 年自動 ESR 分析儀市場預測 – 按類型、分析時間、模式、應用、最終用戶和地區進行的全球分析Automated ESR Analyzer Market Forecasts to 2030 - Global Analysis By Type (Semi-Automated ESR Analyzer & Fully Automated ESR Analyzer), Analysis Time (Less Than 15 Min, 15-30 Min & More Than 30 Min), Modality, Application, End User & By Geography |
根據 Stratistics MRC 的數據,2023 年全球自動化 ESR 分析儀市場規模將達到 3.7572 億美元,預測期內復合年增長率為 6.8%,預計到 2030 年將達到 5954.7 億美元達到100萬美元。
自動紅細胞沉降率 (ESR) 分析儀計算紅細胞從全血落入標準管中的速率(以毫米/小時為單位)。 自動化 ESR 分析儀可提供快速、準確的結果,同時減少勞動密集型手動工作以及與傳統手動 ESR 測量相關的潛在錯誤。 實際上,它有助於防止多個樣本被拒絕。 通過自動化技術獲得快速、準確的 ESR 測量結果,並且與傳統 Westergreen 參考方法表現出極好的一致性。 現代 ESR 方法不需要進一步稀釋,提高了操作員的安全性,優化了實驗室物流流程並減少了浪費。
根據世界衛生組織的數據,2018 年全球 ESR 報告約佔醫療保健相關感染的 10% 和手術部位感染的 50%。
世界各國政府都在尖端醫療檢測技術上投入更多資金。 日本、中國和印度等一些國家的感染率很高。 各國政府正在投入巨資為更多人提供健康和福祉。 為了減輕醫療保健服務的負擔,特別是在新興經濟體,多個監管機構和政府推出了各種削減成本的措施。 所有這些因素都在推動市場需求。
處理血液樣本的醫護人員感染血液傳播疾病的風險很大。 ESR 顯著增加(>100mm/h)的最常見原因包括感染、大量出血、惡性腫瘤和顳關節炎。 這些會導致腎臟損傷和癌症損傷。 因此,不應鼓勵當地測試中心和不熟練的操作人員來預防此類問題。 因此,傳染病的威脅進一步阻礙了市場的擴張。
為了實現快速檢測率,製造商正在開發最先進的設備,例如自動 ESR 分析儀。 現代分析儀直接從 EDTA 管提供 ESR 結果,無需使用患者樣本。 這些分析儀具有最先進的編程、升級的測量算法和數據處理能力。 影響全球市場的技術進步使得自動 ESR 分析儀相對於手動 ESR 分析儀的市場開發得以實現。
ESR 分析儀是一種複雜的設備,需要合格的人員進行血液測試並獲得正確的結果。 缺乏經驗的技術人員可能會在訂單輸入、患者和樣本識別、樣本採集以及錯誤的測試請求等方面犯錯誤。 患者出現問題的風險仍然相當高。 在低收入國家,合格人才的短缺可能導致難以滿足市場需求。
新冠疫情將對市場產生積極影響。 該病毒傳播得如此之快,以至於世界各地的人們都必須接受血液檢查。 血液檢測分析被用作識別 COVID-19 陽性患者的替代方法。 患者的全血細胞計數(CBC)、血漿C反應蛋白(CRP)水平和紅細胞沉降率均使用ESR分析儀測定。 借助自動化 ESR 分析儀,實驗室能夠在短時間內獲得準確的結果。 每天進行數千次血液檢查。 這種時尚給市場帶來了巨大的好處。
全自動 ESR 分析儀領域預計將有良好的增長。 全自動分析儀可提高生產率、交貨時間和實驗室安全性。 從插入樣品管的那一刻起,即可進行無人值守操作。 因此,它比半自動ESR分析儀更實用。 通過最先進的全自動模型,對兒科患者的分析變得更加容易。 該行業的增長是由這些因素推動的。
在預測期內,便攜式市場預計將以最快的複合年增長率增長。 便攜式ESR分析儀是一種採用Westergren分析方法和紅外傳感器測量方法的便攜式設備。 最大處理速度為每小時 80 個樣品,測量範圍為 1 至 140 mm/h。 大多數儀器有兩次測量時間,每次測量時間為 30 或 60 分鐘,最多可同時加載 40 個樣品。 用戶友好且易於識別患者的優點推動了這一細分市場的需求。
由於傳染病、炎症、心髒病、血液疾病、糖尿病和膠原血管疾病等疾病的患病率不斷上升,預計歐洲在預測期內將佔據最大的市場份額。我在這裡。 歐洲是獲取準確和最新的全球癌症統計數據的關鍵地區,因為它對全球癌症負擔做出了重大貢獻。 由於自動化 ESR 分析儀與當前的惡性腫瘤狀況相關,因此隨著癌症發病率的上升,德國對自動化 ESR 分析儀的需求很可能仍將保持在較高水平。
由於血源性感染增加,預計亞太地區在預測期內的複合年增長率最高。 該地區衛生設施不足是感染在人群中傳播的一個關鍵標準。 隨著全自動檢測系統在亞太地區的推出,日本目前在全球享有較大的市場份額。 這是由於老年人口眾多以及與年齡相關的疾病負擔沉重。 此外,由於政府注重加強醫療基礎設施並為其公民提供改善的醫療設施,該地區的工業正在增長。
2023 年 5 月,臨床診斷領導者 Beckman Coulter 宣布推出單位面積生產率最高的 DxI 9000 Access 免疫分析儀。 DxI 9000 分析儀每小時每平方米最多可執行 215 次測試(測試/小時/平方米)。 DxI 9000 分析儀的創新滿足了速度、可靠性、再現性、質量和菜單擴展的要求。
2022 年 3 月,Thermo Fisher Scientific 發布了最新一代 SeqStudio Flex 系列基因分析儀,支持客戶在基因編輯和傳染病等領域進行前沿研究。 SeqStudio Flex 基因分析儀提供最高標準的 CE 技術質量、準確的數據和可靠的性能。
According to Stratistics MRC, the Global Automated ESR Analyzer Market is accounted for $375.72 million in 2023 and is expected to reach $595.47 million by 2030 growing at a CAGR of 6.8% during the forecast period. The automated erythrocyte sedimentation rate (ESR) analyzer calculates the rate in mm per hour at which red blood cells from whole blood fall into a standard tube. Automated ESR analyzers deliver prompt and precise findings while cutting down on the labor-intensive manual work and potential mistakes that come with conventional manual methods of ESR measurement. In practical practice, it aids in preventing the rejection of several samples. Rapid and accurate ESR readings are produced using an automated technique, which also exhibits excellent agreement with the conventional Westergreen reference method. Modern ESR methods do not require further dilution, which enhances operator security, optimizes logistical laboratory process, and reduces waste.
According to the World Health Organization, by worldwide ESR reports in 2018, healthcare associated infection was about 10% and surgical site infections were 50%.
Governments all across the world are spending additional funds on cutting-edge medical testing technology. Infection rates are high in several countries, including Japan, China, and India. Governments are making large expenditures to provide greater health and well-being for more people. To lessen the burden of providing healthcare, several regulatory bodies and governments, particularly in developed economies, are putting in place a variety of cost-cutting measures. All of these factors boost the market demand.
Medical personnel who handle blood samples run a very real risk of contracting a blood-borne illness. The most prevalent causes of a highly increased ESR (>100 mm/hr) include infection, significant blood loss, malignancy, or temporal arthritis. They may result in renal or cancer disorders. Therefore, in order to prevent such issues, local testing centers and unskilled operators should not be encouraged. Therefore, the threat of infections is impeding market expansion even more.
In order to offer a quick detection rate, manufacturers are creating cutting-edge equipment like automated ESR analyzers. The newest developments in analyzers give ESR findings straight from EDTA tubes without using the patient sample. These analyzers have cutting-edge programming, upgraded measuring algorithms, and increased data-handling capabilities. The development of automated ESR analyzers beyond manual ESR analyzers is currently possible because to technological advancements, which are influencing the worldwide market.
ESR analyzers are intricate devices that need for qualified personnel to do blood tests and provide correct findings. Unskilled technicians may make mistakes in order input, patient and specimen identification, sample collection, and incorrect test requests. Patients still run a considerable risk of developing problems. Low-income nations may experience difficulties meeting market demand due to a lack of qualified personnel.
The covid pandemic has the positive impact on the market. As the virus spread rapidly, it became necessary for all the people around the world to have blood tests. Blood test analysis is used as an alternative for identifying COVID-19-positive patients. The patient's complete blood count (CBC), plasma levels of C-reactive protein (CRP), and erythrocyte sedimentation rate were all examined using ESR analyzers. The laboratories received accurate outcomes in a shorter amount of time because of the automated ESR analyzers. Every day, thousands of blood tests were carried out. The epidemic profited the market hugely.
The fully automated ESR analyzer segment is estimated to have a lucrative growth. Fully automated analyzers enhance productivity, turnaround time, and lab security. From the moment the sample tube is inserted, it allows walk-away operation. This makes it more practical than ESR analyzers that are semi-automated. The analysis of paediatric patients is made simpler when cutting-edge, completely automated analyser models are employed. The segment's growth is being fuelled by these factors.
The portable segment is anticipated to witness the fastest CAGR growth during the forecast period. Portable ESR analyzers are portable devices that employ the Westergren analysis technique and the infrared sensor measuring idea. They have an hourly processing rate of up to 80 samples and a measurement range of 1 to 140 mm/h. The majority of devices have two measurement times of 30 or 60 minutes each and a maximum simultaneous sample loading capacity of 40. The segment's demand is being fueled by its benefits for user-friendly and simple patient identification.
Europe is projected to hold the largest market share during the forecast period owing to the rising prevalence of disorders such infection, inflammation, heart disease, blood disease, diabetes, and collagen vascular diseases. Europe is a key area of attention for getting accurate and current global cancer statistics due to its large contribution to the global cancer burden. It is very likely that demand for automated ESR analyzers will stay high in Germany as cancer prevalence grows since ESR analyzers are linked to the symptoms of present malignancies.
Asia Pacific is projected to have the highest CAGR over the forecast period, owing to raising blood borne infections. Inadequate sanitation conditions in this region are the main criteria for growing infections among population. With the introduction of fully automated laboratory systems in the Asia Pacific area, Japan now enjoys a greater market share globally. This is attributed to the large geriatric population bringing in a heavy disease burden associated with age-related disorders. Additionally, the region's industry is growing as a result of the government's focus on enhancing the healthcare infrastructure and offering the populace improved healthcare facilities.
Some of the key players profiled in the Automated ESR Analyzer Market include ALCOR Scientific Inc, RR Mechatronics, Beijing Succeeder Technology Inc, Streck Inc, ELITechGroup, Greiner Bio One International GmbH, SFRI Medical Diagnostics, Alifax Holding S.p.A., Thermo Fisher Scientific Inc, Diesse Diagnostica Senese SPA, Hospitex Diagnostics, Caretium Medical Instruments Co, Streck Laboratories, Beckman Coulter Inc and Perlong Medical Equipment Co Ltd.
In May 2023, Beckman Coulter, a clinical diagnostics leader, unveiled the DxI 9000 Access Immunoassay Analyzer, the most productive immunoassay analyzer per footprint. The DxI 9000 Analyzer can run up to 215 tests per hour per square meter (tests/hr/m2). The DxI 9000 Analyzer innovations address speed, reliability, reproducibility, quality, and menu expansion demands.
In March 2022, Thermo Fisher Scientific introduced its latest generation of SeqStudio Flex Series Genetic Analyzer to enable customers' cutting-edge research in areas such as gene editing and infectious disease. The SeqStudio Flex Genetic Analyzer delivers the gold-standard quality of CE technology with accurate data and reliable performance.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.